# Merck Animal Health Ventures

> Merck Animal Health Ventures is a VC fund in Madison backing Biotechnology and AgTech. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Madison, United States
- Total investments: 4
- Last investment: Jun 2026
- Lead investor: 25%
- Last updated: Aug 2026
- Website: https://www.merck-animal-health.com/animal-health-ventures/

Merck Animal Health Ventures is a VC fund in Madison focused on Biotechnology and AgTech. Merck Animal Health Ventures partners with companies and invests in bringing new solutions to address unmet customer needs, including advanced digital technologies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| AgTech | 1 | 25% |
| Software | 1 | 25% |
| Livestock | 1 | 25% |
| Animal Feed | 1 | 25% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rejuvenate Bio | Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA. | $6M | Venture - Series Unknown | Jun 08, 2026 |  |
| TARGAN | Applied LifeSciences & Systems is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effectivevaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick. | $35M | Series C | May 25, 2022 |  |
| Vence | Vence makes a hardware solution for cattle which when combined with their application software allows farmers to remotely manage/control their livestock. Their solution increases the utilization of the available grasses (increased the number of animals on a farm), removes costs associated with fencing (hardware/ maintenance costs/labor) and eliminates labor associated with moving the animals. |  | Series A | Mar 16, 2022 |  |
| TARGAN | Applied LifeSciences & Systems is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effectivevaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick. | $7M | Series B | May 12, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Mountain Group Capital](https://shizune.co/investors/profile/mountain-group-capital) — VC Fund, 2 deals together
- [Oval Park Capital](https://shizune.co/investors/profile/oval-park-capital) — VC Fund, 2 deals together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 1 deal together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 1 deal together
- [Kendall Capital Partners](https://shizune.co/investors/profile/kendall-capital-partners) — VC Fund, 1 deal together
- [Novaquest Capital Management](https://shizune.co/investors/profile/novaquest-capital-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Merck Animal Health Ventures invest in?

Merck Animal Health Ventures invests primarily in Biotechnology, AgTech and Software startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Merck Animal Health Ventures last invest?

The most recent investment recorded for Merck Animal Health Ventures closed in Jun 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co